[go: up one dir, main page]

PT3258927T - Mimeticos da proteína de defesa hospedeira (hdp) para profilaxia e/ou tratamento de doenças inflamatórias do trato gastrointestinal - Google Patents

Mimeticos da proteína de defesa hospedeira (hdp) para profilaxia e/ou tratamento de doenças inflamatórias do trato gastrointestinal

Info

Publication number
PT3258927T
PT3258927T PT167527993T PT16752799T PT3258927T PT 3258927 T PT3258927 T PT 3258927T PT 167527993 T PT167527993 T PT 167527993T PT 16752799 T PT16752799 T PT 16752799T PT 3258927 T PT3258927 T PT 3258927T
Authority
PT
Portugal
Prior art keywords
hdp
mimetics
prophylaxis
treatment
gastrointestinal tract
Prior art date
Application number
PT167527993T
Other languages
English (en)
Original Assignee
Innovation Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovation Pharmaceuticals Inc filed Critical Innovation Pharmaceuticals Inc
Publication of PT3258927T publication Critical patent/PT3258927T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT167527993T 2015-02-20 2016-02-09 Mimeticos da proteína de defesa hospedeira (hdp) para profilaxia e/ou tratamento de doenças inflamatórias do trato gastrointestinal PT3258927T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562118950P 2015-02-20 2015-02-20

Publications (1)

Publication Number Publication Date
PT3258927T true PT3258927T (pt) 2021-07-22

Family

ID=56689106

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167527993T PT3258927T (pt) 2015-02-20 2016-02-09 Mimeticos da proteína de defesa hospedeira (hdp) para profilaxia e/ou tratamento de doenças inflamatórias do trato gastrointestinal

Country Status (15)

Country Link
US (3) US20160243117A1 (pt)
EP (1) EP3258927B8 (pt)
JP (1) JP6047203B2 (pt)
CN (1) CN107613967A (pt)
AU (1) AU2016220373B2 (pt)
DK (1) DK3258927T3 (pt)
ES (1) ES2881429T3 (pt)
HR (1) HRP20211107T1 (pt)
HU (1) HUE055090T2 (pt)
LT (1) LT3258927T (pt)
PL (1) PL3258927T3 (pt)
PT (1) PT3258927T (pt)
RS (1) RS62249B1 (pt)
SI (1) SI3258927T1 (pt)
WO (1) WO2016133733A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
US8802683B2 (en) 2011-05-16 2014-08-12 Cellceutix Corporation Compounds for use in treatment of mucositis
TN2018000069A1 (en) 2015-09-01 2019-07-08 First Wave Biopharma Methods and compositions for treating conditions associated with an abnormal inflammatory responses
EP3908276A1 (en) * 2019-01-08 2021-11-17 Arena Pharmaceuticals, Inc. METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR



US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment
WO2021248008A1 (en) 2020-06-05 2021-12-09 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629317B2 (en) * 2001-03-29 2009-12-08 The University Of Chicago Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
ES2433663T3 (es) * 2004-06-15 2013-12-12 Polymedix, Inc. Compuestos policatiónicos y usos de los mismos
US8017576B2 (en) * 2005-05-10 2011-09-13 The University Of Chicago Methods and compositions to treat mucositis
US8202835B2 (en) * 2005-06-17 2012-06-19 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
US20090092574A1 (en) * 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
TWI478915B (zh) * 2008-10-27 2015-04-01 Cellceutix Corp 宿主防禦之合成模擬物及其用途
US8802683B2 (en) * 2011-05-16 2014-08-12 Cellceutix Corporation Compounds for use in treatment of mucositis

Also Published As

Publication number Publication date
JP6047203B2 (ja) 2016-12-21
SI3258927T1 (sl) 2022-03-31
JP2016153386A (ja) 2016-08-25
AU2016220373B2 (en) 2020-10-22
RS62249B1 (sr) 2021-09-30
AU2016220373A1 (en) 2017-10-12
US20230310435A1 (en) 2023-10-05
PL3258927T3 (pl) 2021-11-08
HRP20211107T1 (hr) 2021-10-15
HUE055090T2 (hu) 2021-10-28
WO2016133733A1 (en) 2016-08-25
EP3258927B1 (en) 2021-06-09
EP3258927B8 (en) 2021-09-15
EP3258927A4 (en) 2018-11-21
US20200368232A1 (en) 2020-11-26
LT3258927T (lt) 2021-09-27
US11666571B2 (en) 2023-06-06
ES2881429T3 (es) 2021-11-29
DK3258927T3 (da) 2021-07-19
EP3258927A1 (en) 2017-12-27
US20160243117A1 (en) 2016-08-25
CN107613967A (zh) 2018-01-19

Similar Documents

Publication Publication Date Title
ZA201807098B (en) Cannabionid and cannabis-based compositions and methods for the treatment of inflammatory conditions of the gastrointestinal tract
LT3258927T (lt) Šeimininko apsauginių baltymų (hdp) mimetikai, skirti uždegiminių virškinamojo trakto ligų profilaktikai ir (arba) gydymui
IL256630B (en) Combined separator and coagulator
GB2554354B (en) Systems for adaptive treatment of disorders in the gastrointestinal tract
EP3348273B8 (en) Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
ZA201903893B (en) Treatment of respiratory tract diseases and infections with glutathione compositions
EP3428178A4 (en) PEPTIDE FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY DISEASES AND USE THEREOF
HK1256167A1 (zh) 用於治療或預防癌症和神經疾病的包括15-hepe的組合物
EP3509614A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF LAFORA DISEASE
RS65173B1 (sr) Kompozicija za prevenciju i/ili lečenje simptoma alergije
GB201515244D0 (en) Treatment of inflammatory disease or condition
ZA201903222B (en) Compositions and methods for the treatment of gastrointestinal polyps
GB201522329D0 (en) Use of adjuvants for the prevention and/or treatment of autoimmune diseases
SG11201704430SA (en) Preventive and/or therapeutic agent of immune disease
EP3428179A4 (en) PEPTIDE FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY DISEASES AND USE THEREOF
IL257689B (en) Pharmaceutical preparations and methods for treating diseases related to lack of oxygen
WO2015113041A3 (en) Compositions and methods for treating autoimmune and inflammatory diseases
AU2018903823A0 (en) Compositions and methods of treatment of conditions of the gastrointestinal tract
GB201809835D0 (en) Treatment of gastrointestinal disease
HUE065317T2 (hu) Készítmény gyulladásos fertõzõ betegségek kezelésére és/vagy megelõzésére
AU2015900887A0 (en) Treatment and detection of inflammatory disease
EP3270963A4 (en) Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
AU2015902358A0 (en) Treatment of inflammatory disease
GB201515440D0 (en) Theraputic and diagnostic target
GB201515441D0 (en) Theraputic and diagnostic target